AI Detects Hidden Heart Attack Risk in Patients Cleared by Traditional Calcium Scans

A groundbreaking study presented at the Society of Cardiovascular Computed Tomography (SCCT) conference reveals that artificial intelligence can identify high-risk cardiovascular patients who would be missed entirely by traditional screening methods. The research demonstrates that AI-powered analysis of coronary inflammation from standard CT scans can detect elevated heart attack and stroke risk even in patients with reassuringly low or zero coronary artery calcium (CAC) scores—a finding that could fundamentally reshape how clinicians assess cardiovascular danger.

For decades, calcium scoring has served as a cornerstone of cardiac risk assessment, with zero or low scores generally interpreted as indicators of minimal cardiovascular threat. This new research, presented by Dr. Kenneth Chan, MBBS, suggests that significant numbers of patients may be receiving false reassurance from their calcium scores while harboring dangerous inflammatory processes that substantially elevate their risk.

Beyond Calcium: The Inflammation Blind Spot

Traditional coronary artery calcium scoring measures calcified plaque deposits in the heart's arteries, providing valuable information about atherosclerotic burden. However, this approach has a critical limitation: it cannot detect inflammatory activity within arterial walls, which plays a crucial role in plaque rupture and acute cardiovascular events.

The AI technology examined in the study analyzes standard CT imaging to identify inflammatory markers around coronary arteries, effectively revealing a dimension of cardiovascular risk that remains invisible to conventional calcium scoring. This capability addresses a significant clinical gap, as patients with zero or low CAC scores represent a substantial portion of those undergoing cardiac screening—many of whom may be at higher risk than their calcium scores suggest.

Clinical Implications for Risk Stratification

The findings have immediate implications for cardiovascular risk management. Clinicians have long recognized that some patients with low calcium scores still experience heart attacks and other cardiovascular events, but lacked tools to identify which seemingly low-risk individuals actually face elevated danger. AI-powered inflammation assessment could enable physicians to refine treatment decisions, potentially initiating preventive therapies—including statins, blood pressure medications, or lifestyle interventions—in patients who would otherwise receive no treatment based on their calcium scores alone.

This more nuanced approach to risk stratification could prevent cardiovascular events in a previously overlooked patient population. Rather than replacing calcium scoring, inflammation measurement appears positioned to complement existing screening protocols, adding a critical layer of information that captures inflammatory risk independent of calcified plaque burden.

Looking Ahead

The research validates an emerging category within cardiac imaging AI, with significant implications for health technology companies developing advanced cardiac analysis algorithms. As the technology moves toward clinical adoption, healthcare systems will need to evaluate how to integrate inflammation assessment into existing cardiovascular screening workflows and determine which patient populations benefit most from this enhanced risk evaluation.

For patients, the technology offers the promise of more accurate risk assessment, though it also introduces complexity—some individuals reassured by zero calcium scores may learn they face higher risk than previously understood, necessitating careful communication and shared decision-making about preventive interventions.

Sources

1. Study: AI Measurement of Coronary Inflammation from CT Scans Can Identify High CV Risk Patients with Low or Zero CAC Scores — Diagnostic Imaging